INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹12 Cr | ₹9.91 Cr | ₹9.14 Cr | ₹47 Cr | ₹18 Cr |
What is the latest Long Term Provisions ratio of INNOVA CAPTAB ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹12 Cr |
| Mar2025 | ₹9.91 Cr |
| Mar2024 | ₹9.14 Cr |
| Mar2023 | ₹47 Cr |
| Mar2022 | ₹18 Cr |
How is Long Term Provisions of INNOVA CAPTAB Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | 20.31 | |
| Mar2025 | ₹9.91 Cr | 8.32 | |
| Mar2024 | ₹9.14 Cr | -80.47 | |
| Mar2023 | ₹47 Cr | 156.83 | |
| Mar2022 | ₹18 Cr | - | |
Compare Long Term Provisions of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹6,678.7 Cr | -8.9% | 9.6% | 37.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -8.9% |
9.6% |
37.7% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses